Taxol affects nuclear lamina and pore complex organization and inhibits import of karyophilic proteins into the cell nucleus

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4625-4633

  Theodoropoulos, Panayiotis A ^a   Polioudaki, Hara ^a   Kostaki, Olga ^a   Derdas, Stavros P ^a   Georgoulias, Vassilis ^a   Dargemont, Catherine ^b   Georgatos, Spyros D ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR PROTEIN; PACLITAXEL; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL NUCLEUS MEMBRANE; CELL ULTRASTRUCTURE; CHANNEL GATING; CONTROLLED STUDY; DNA REPLICATION; DRUG MECHANISM; HUMAN; HUMAN CELL; MEMBRANE STRUCTURE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

EID: 0033567928     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Rowinsky, E. K., and Donehower, R. S. Paclitaxel (Taxol). N. Engl. J. Med, 332: 1004-1014, 1995.
2. Arnal, I., and Wade, R. H How does Taxol stabilize microtubules? Curr. Biol., 5: 900-908, 1995.
3. Mickey, B., and Howard, J. Rigidity of microtubules is increased by stabilizing agents. J. Cell Biol., 130: 909-917, 1995.
4. Jordan, M. A., Toso, R. J., Thrower, D., and Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc. Natl. Acad. Sci. USA, 90: 9552-9556, 1993.
5. Jordan, M. A., Wendell, K., Gardiner, S., Derry, B., Copp, H., and Wilson, L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res., 56: 816-825, 1996.
6. Danesi, R., Figg, W., Reed, E., and Myers, C. E. Paclitaxel (Taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells. Mol. Pharmacol., 47: 1106-1111, 1995.
7. Woods, C. M., Zhu, J., McQueney, P. A., Bollag, D., and Lazarides, E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med., 1: 506-526, 1995.
8. Ding, A. H., Porteu, F., Sanchez, E., and Nathan, C. F. Shared actions of endotoxin and Taxol on TNF receptors and TNF release. Science (Washington DC), 248: 370-372, 1990.
9. Burkhart, C. A., Berman, J. W., Swindell, C. S., and Horwitz, S. B. Relationship between the structure of Taxol and other taxanes on induction of tumor necrosis factor-α gene expression and cytotoxicity. Cancer Res., 54: 5779-5782, 1994.
10. Bogdan, C., and Ding, A. Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. J. Leukocyte Biol., 52: 119-121, 1992.
11. Lee, L-F., Schuerer-Maly, C-C., Lofquist, A. K., van Haaften-Day, C., Ting, J. P-Y., White, C. M., Martin, B. K., and Haskill, J. S. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer. Cancer Res., 56: 1303-1308, 1996.
12. Moos, P. J., and Fitzpatrick, F. A. Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoplosis. Proc. Natl. Acad. Sci. USA, 95; 3896-3901, 1998.
13. Blagosklonny, M. V., Schulte, T. W., Nguyen, P., Trepel, J., and Neckers, L. Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res., 56: 1851-1854, 1996.
14. Haldar, S., Basu, A., and Croce, C. M. Bcl2 is the guardian of microtubule integrity. Cancer Res., 57: 229-233, 1997.
15. Jordan, M. A., Thrower, D., and Wilson, L. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J. Cell Sci., 102: 401-416, 1992.
16. Compton, D. A. and Cleveland, D. W. NuMA is required for the proper completion of mitosis. J. Cell Biol., 120: 947-957, 1993.
17. Demeter, J., Morphew, M., and Sazer, S. A mutation in the RCC1-related protein pim1 results in nuclear envelope fragmentation in fission yeast. Proc. Natl. Acad. Sci. USA, 92: 1436-1440, 1995.
18. Georgatos, S. D. Towards an understanding of nuclear morphogenesis. J. Cell. Biochem., 55: 69-76, 1994.
19. Gerace, L., and Burke, B. Functional organization of the nuclear envelope. Annu. Rev. Cell Biol., 4: 335-374, 1988.
20. Georgatos, S. D., Pyrpasopoulou, A., and Theodoropoulos, P. A. Nuclear envelope breakdown in mammalian cells involves stepwise lamina disassembly and microtubule-driven deformation of the nuclear membrane. J. Cell Sci., 110: 2129-2140, 1997.
21. Maison, C., Pyrpasopoulou, A., Theodoropoulos, P. A., and Georgatos, S. D. The inner nuclear membrane protein LAP1 forms a native complex with B-type lamins and partitions with spindle-associated mitotic vesicles. EMBO J., 16: 4839-4850, 1997.
22. Maison, C., Horstmann, H., and Georgatos, S. Regulated docking of nuclear membrane vesicles to vimentin filaments during mitosis. J. Cell Biol., 123: 1491-1505, 1993.
23. Theodoropoulos, P. A., Polioudaki, H., Koulentaki, M., Kouroumalis, E. and Georgatos, S. D. PBC68: a nuclear pore complex protein that associates reversibly with the mitotic spindle. J. Cell Sci., in press, 1999.
24. Davis, L. I., and Blobel, G. Identification and characterization of a nuclear pore complex protein. Cell, 45: 699-709, 1986.
25. Pyrpasopoulou, A., Meier, J., Maison, C., Simos, G., and Georgatos, S. D. The lamin B receptor (LBR) provides essential chromatin docking sites at the nuclear envelope. EMBO J., 15: 7108-7119, 1996.
26. Meier, J., and Georgatos, S. D. Type B lamins remain associated with the integral membrane protein p58 during mitosis: implications for nuclear reassembly. EMBO J., 13: 1888-1898, 1994.
27. Djabali, K., Portier, M.-M., Gros, F., Blobel, G., and Georgatos, S. D. Network antibodies identify nuclear lamin B as a physiological attachment site for peripherin intermediate filaments. Cell, 64: 109-121, 1991.
28. Louvard, D., Reggio, H., and Warren, G. Antibodies to the Golgi complex and the rough endoplasmic reticulum. J. Cell Biol., 92: 92-107, 1982.
29. Van Engeland, M., Nieland, L. J. W., Ramaekers, F. C. S., Schutte, B., and Reutelingsperger, C. P. M. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry, 31: 1-9, 1998.
30. Kroemer, G., Bosca, L., Zamzami, N., Marched, P., Hortelano, S., and Martinez, A. C. Detection of apoptosis and apoptosis-associated alterations, Immunol. Methods Manual, 14.2: 1111-1124, 1997.
31. Adam, S. A., Sterne-Marr, R., and Gerace, L. Nuclear protein import using digitonin-permeabilized cells. Methods Enzymol., 219: 97-110, 1992.
32. 0 gene results in defective nuclear envelopes, clustering of nuclear pore complexes, and accumulation of annulate lamellae. J. Cell Biol., 137: 1001-1016, 1997.
33. Belgareh, N., and Doye, V. Dynamics of nuclear pore distribution in nucleoporin mutant yeast cells. J. Cell Biol., 136: 747-759, 1997.
34. McCloskey, D. E., Kaufmann, S. H., Prestigiacomo, L. J., and Davidson, N. E. Paclitaxel induces programmed cell death in MDA-MB-468 human breast cancer cells. Clin. Cancer Res., 2: 847-854, 1996.
35. Dalton, M. B., Fantle, K. S., Bechtold, H. A., DeMaio, L., Evans, R. M., Krystosek, A., and Sinensky, M. The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localization. Cancer Res., 55: 3295-3304, 1995.
36. Shtil, A. A., Mandlekar, S., Yu, R., Walter, R. J., Hagen, K., Tan, T. H., Roninson, I. B., and Kong, A. N. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Oncogene, 18: 377-384, 1999.
37. Cliby, W. A., Roberts, C. J., Cimprich, K. A., Stringer, C. M., Lamb, J. R., Schreiber, S. L., and Friend, S. H. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J., 17: 159-169, 1998.
38. Bentley, N. J., Holtzman, D. A., Flaggs, G., Keegan, K. S., DeMaggio, A., Ford, J. C., Hoekstra, M. F., and Carr, A. M. The Schizosaccharomyces pombe rad3 checkpoint gene. EMBO J., 15: 6641-6651, 1996.
39. Dechat, T., Gotzmann, J., Stockinger, A., Harris, C. A., Talle, M. A., Siekierka, J. J., and Foisner, R. Detergent-salt resistance of LAP-2α in interphase nuclei and phosphorylation-dependent association with chromosomes early in nuclear assembly implies functions in nuclear structure dynamics. EMBO J., 17: 4887-4902, 1998.
40. Zatsepina, O. V., Rousselet, A., Chan, P. K., Olson, M. O., Jordan, E. G., and Bornens, M. The nucleolar phosphoprotein B23 redistributes in part to the spindle poles during mitosis. J. Cell Sci., 112: 455-466, 1999.
41. Beg, A. A., and Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science (Washington DC), 274: 782-784, 1996.
42. Wang, C-Y., Mayo, M. W., and Baldwin, A. S., Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science (Washington DC), 274: 784-787, 1996.
43. Wang, C-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., Jr. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and C-1AP2 to suppress caspase-8 activation. Science (Washington DC), 281: 1680-1683, 1998.
44. Seong, J., Milross, C. G., Hunter, N. R., Shin, H. C., and Milas, L. Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-α. Anticancer Drugs, 8: 80-87, 1997.
45. Ashkenazi, A., and Dixit, V. M. Death receptors: signaling and modulation. Science (Washington DC), 281: 1305-1308, 1998.
46. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., and Baldwin, A. S., Jr. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science (Washington DC), 270: 283-286, 1995.
47. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., and Karin, M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science (Washington DC), 270: 286-290, 1995.
48. Kopp, E., and Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science (Washington DC), 265: 956-959, 1994.